Qube Research & Technologies LTD Ovid Therapeutics Inc. Transaction History

Qube Research & Technologies LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$2.72 - $4.04 $146 - $218	54 New	54 $0
Q1 2022 May 09, 2022	SELL	$2.65 - $3.49 $37,070 - $48,821	-13,989 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$3.13 - $3.73 $43,785 - $52,178	13,989 New	13,989 $45,000
Q2 2020 Aug 14, 2020	SELL	$2.67 - $7.91 $59,920 - $177,516	-22,442 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$2.03 - $4.35 $464,504 - $995,366	-228,820 Reduced 91.07%	22,442 $67,000
Q4 2019 Feb 13, 2020	BUY	$2.08 - $5.06 $522,624 - $1.27 Million	251,262 New	251,262 $1.04 Million

39M

37.4K

500

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $73.2M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.